Washington, D.C.—The Consumer Healthcare Products Association (CHPA) launched its Self-Care Leadership Series with a Fireside Chat with Dr. Scott Gottlieb, which covered a range of topics including COVID-19 and CBD. On the latter, the former Food and Drug Administration (FDA) Commissioner noted that dietary supplements are becoming more complex in...
Washington, D.C.--The word in Washington is that oncologist Stephen Hahn, M.D., who currently serves as the chief medical executive at MD Anderson Cancer Center in Houston, is President Trump's pick to lead the Food and Drug Administration (FDA). STAT News reported that a person familiar with the White House's thinking...
Washington, D.C.—Dr. Norman E. Sharpless, director of the National Cancer Institute, will serve as acting commissioner of the Food and Drug Administration, according to the New York Times, which cited an announcement by Alex M. Azar III, the secretary of Health and Human Services. Dr. Sharpless has been director of...
Washington, D.C.—Scott Gottlieb, commissioner of the Food and Drug Administration, announced his resignation, effective in April. The announcement came at the start of Expo West, causing much buzz and speculation as to what had led to the resignation—and what the impact would be for the natural products industry. The New...
Washington, D.C. — The Senate voted 57–42 to confirm Scott Gottlieb as the U.S. Food and Drug Administration’s (FDA) new commissioner reports the New York Times. Industry has been watching Gottlieb’s confirmation hearings closely, as senators questioned the nominee, trying to determine how he would approach dietary supplements. We got...
Scott Gottlieb, M.D. — President Donald Trump’s nominee for Food and Drug Administration (FDA) commissioner — publicly confirmed his support and commitment to enforce the Dietary Supplement Health and Education Act of 1994 (DSHEA) if he is confirmed as commissioner. “As someone who uses dietary supplements every day, I believe...
Chevy Chase, MD – According to a press release by New Enterprise Associates, Inc., President Donald J. Trump has nominated the firm’s Venture Partner Scott Gottlieb, M.D. as Commissioner of the United States Food and Drug Administration (FDA). A policy expert, Gottlieb has substantial experience in health care, holding roles...
